Navigation

© Zeal News Africa

Urine Biomarker Revealed: Experts Link Key Changes To Early Dementia Warning

Published 4 weeks ago3 minute read
Precious Eseaye
Precious Eseaye
Urine Biomarker Revealed: Experts Link Key Changes To Early Dementia Warning

Recent research indicates a subtle change in urine habits, specifically foamy urine, could significantly elevate the risk of developing dementia. This concerning discovery by Swedish researchers suggests that individuals experiencing foamy urine, which can also lead to more frequent urination, might face up to a 40 percent higher risk of developing the memory-robbing condition. This finding builds upon existing knowledge linking conditions like constipation and gut microbiome imbalances to cognitive decline.

Scientists propose that the underlying cause for foamy urine in this context is high levels of the protein albumin, a result of damaged kidneys that 'leak' albumin through their filters. The association was found to be particularly strong for vascular dementia, which is the second most prevalent form of dementia after Alzheimer's disease and mixed dementia.

Dr. Hong Xu, an assistant professor in neurobiology at the Karolinska Institute, highlighted the interconnectedness of bodily systems, stating, 'The kidneys and the brain may seem like very different organs, but they share an important characteristic: both depend on a delicate network of small blood vessels. When the blood vessels in the kidneys are damaged, the same process often occurs in the brain.' This underscores that issues in other parts of the body, such as kidney health, can indeed act as risk factors for dementia.

The findings emphasize the critical role of routine screening for albuminuria, which is the medical term for too much albumin in the urine. This screening is particularly important as part of early dementia risk assessment, especially for patients who have high blood pressure, diabetes, cardiovascular disease, or existing kidney disease. Early detection of albuminuria holds the potential to delay or even prevent the onset of dementia.

In a comprehensive study, researchers tracked 130,000 older adults in Stockholm, all over 65 years old and without dementia at the outset. Over a four-year follow-up period, seven percent of the participants developed dementia. After meticulously accounting for kidney function and other potential confounding factors, the study revealed that individuals with moderate levels of albumin in their urine (30–299 mg/g) had a 25 percent higher risk of developing dementia. Those with high levels (more than 300 mg/g) faced an even greater risk, at 37 percent higher compared to individuals with normal albumin levels (up to 30 mg/g).

It is important to note that not everyone with albuminuria will experience symptoms. However, if symptoms do appear, they can include foamy pee, frequent urination, puffy eyes, and swelling in the feet, ankles, belly, or face. A simple urine test is considered the most effective method for diagnosing albuminuria, and experts urge those at higher risk of albuminuria or kidney disease to undergo regular health check-ups. Healthy kidneys effectively filter out protein, preventing it from leaking into urine. However, if they are damaged, albumin can bypass these filters.

The researchers, writing in the Journal of Internal Medicine, concluded that 'our statistical data suggest that increased albuminuria is associated with a higher risk of all-cause dementia, particularly vascular and mixed dementia. Early detection of albuminuria may enable more proactive management of kidney health and cognitive function, potentially delaying or preventing the onset of dementia.' Memory problems, difficulties with thinking and reasoning, and language problems are common early symptoms of dementia, which progressively worsen over time.

Dementia remains a significant public health challenge. Approximately 900,000 Britons are currently thought to be living with the disorder, a number that University College London scientists estimate will surge to 1.7 million within two decades as life expectancy increases. This projected rise marks a 40 percent uptick from forecasts made in 2017. Furthermore, Alzheimer's Research UK analysis revealed that 74,261 people died from dementia in 2022, an increase from 69,178 a year prior, solidifying its position as the country's biggest killer.

Loading...
Loading...

You may also like...